Evidence map›Paper›PMID 31067341›Full record

ArticleAngewandte Chemie (International ed. in English)2019

Ligand-Controlled Regiodivergent Enantioselective Rhodium-Catalyzed Alkene Hydroboration.

Andrew J Bochat, Veronika M Shoba, James M Takacs

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Asymmetric Catalytic Hydroboration of Enol Carbamates Enables an Enantioselective Matteson Homologation.Synlett : accounts and rapid communications in synthetic organic chemistry · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrew J BochatDepartment of Chemistry and Nebraska Center for Integrated Biomolecular Communication, University of Nebraska-Lincoln, 807 Hamilton Hall, Lincoln, NE, 68588-0304, USA.ORCID 0000-0002-5056-4555
Veronika M ShobaDepartment of Chemistry and Nebraska Center for Integrated Biomolecular Communication, University of Nebraska-Lincoln, 807 Hamilton Hall, Lincoln, NE, 68588-0304, USA.ORCID 0000-0003-0402-7414
James M TakacsDepartment of Chemistry and Nebraska Center for Integrated Biomolecular Communication, University of Nebraska-Lincoln, 807 Hamilton Hall, Lincoln, NE, 68588-0304, USA.ORCID 0000-0002-1903-6535

Funding

Catalytic Asymmetric Hydroboration: Uncapping the Potential with Two-Point Binding SubstratesR01GM100101 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI TAKACS, JAMES M · 2012 to 2020
$2.1M
NIGMS NIH HHS R01 GM100101NIGMS NIH HHS R01-GM100101
6 · The paper itself

Abstract

Regiocontrol in the rhodium-catalyzed boration of vinyl arenes is typically dominated by the presence of the conjugated aryl substituent. However, small differences in TADDOL-derived chiral monophosphite ligands can override this effect and direct rhodium-catalyzed hydroboration of β-aryl and β-heteroaryl methylidenes by pinacolborane to selectively produce either chiral primary or tertiary borated products. The regiodivergent behavior is coupled with enantiodivergent addition of the borane. The nature of the TADDOL backbone substituents and that of the phosphite moiety function synergistically to direct the sense and extent of regioselectivity and enantioinduction. Twenty substrates are shown to undergo each reaction mode with regioselectivity values reaching greater than 20:1 and enantiomer ratios reaching up to 98:2. A variety of subsequent transformations illustrate the potential utility of each product.

Indexed as

LigandsAlkenesCatalysisMolecular StructureRhodiumStereoisomerismAlkenesLigandsRhodiumasymmetric catalysishomogeneous catalysishydroborationregiodivergent reactionsrhodium

Identifiers

PMID31067341
PMCPMC6663592

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.